Michael Gibertini brings over 30 years of experience to Elligo Health Research. Prior to joining the team, Gibertini served as the president of clinical development at Syneos Health (formerly INC Research) leading a high-growth, scientifically oriented CNS business unit. During his tenure at the company he was responsible for multiple organizational innovations that produced industry-leading growth and success.
Gibertini’s career began in the United States Air Force as a resident in clinical psychology. He held positions of increasing responsibility at the University of South Florida where he received his postdoctoral fellow from the Department of Medical Microbiology and Immunology. From there he went on to work as a senior laboratory scientist in behavioral immunology and environmental toxicology at the Midwest Research Institute before joining Organon Pharmaceuticals as the clinical development team leader in neuroscience.